Pre-Open Movers 06/30: (CARV) (BYFC) (BLNK) Higher; (OCX) (ZYNE) (GNW) Lower (more...)
Pre-Open Stock Movers
Carver Bancorp (NASDAQ: CARV) 174.6% HIGHER; higher after Netflix said it will allocate $100M in cash to black community banks.
Broadway Financial (NASDAQ: BYFC) 88% HIGHER; higher after Netflix said it will allocate $100M in cash to black community banks.
Blink Charging (NASDAQ: BLNK) 54% HIGHER; sees added momentum
Oncocyte Corporation (NYSE: OCX) 48.6% LOWER; announced the completion of the Clinical Validation study of DetermaDx, the Companys liquid biopsy test intended to clarify whether a lung nodule is suspicious or likely benign. Findings from the Clinical Validation study demonstrated that the performance of DetermaDx did not meet the predetermined endpoints for the study.
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) 42% LOWER; announced top line results from the 14-week pivotal CONNECT-FX (Clinical study of Cannabidiol (CBD) in Children and Adolescents with Fragile X) trial. The multi-national, randomized, double-blind, placebo-controlled trial assessed the efficacy and safety of Zygel CBD gel as a treatment in for behavioral symptoms of Fragile X syndrome (FXS) in 212 patients.
Workhorse Group (NASDAQ: WKHS) 25% HIGHER; Extends Recent Gain
Genworth Financial, Inc. (NYSE: GNW) 20.2% LOWER; announced today that it is moving forward with plans to address its near-term liabilities and financial obligations, and maximize shareholder value while China Oceanwide Holdings Group Co., Ltd. (Oceanwide) finalizes its funding plan for the acquisition of Genworth. Genworth and Oceanwide also announced that they have agreed to a 15th waiver and agreement of each party's right to terminate the previously announced merger agreement. The 15th waiver extends the previous deadline of June 30, 2020 to no later than September 30, 2020.
Qumu Corporation (Nasdaq: QUMU) 18.8% HIGHER; Synacor and Qumu announced that the companies have mutually agreed to terminate their proposed all-stock merger agreement, previously announced on February 11, 2020.
Liquidia Technologies, Inc. (NASDAQ: LQDA) 18.1% LOWER; announced today that it has commenced an underwritten public offering of its common stock
9 Meter Biopharma (NASDAQ: NMTR) 15% HIGHER; SunTrust initiates coverage on with a Buy rating and a price target of $5.00.
INOVIO (NASDAQ: INO) 13.7% LOWER; announced positive interim clinical data of INO-4800, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the first two Phase 1 clinical trial cohorts. In addition, INO-4800 has been selected to participate in a non-human primate (NHP) challenge study as part of the U.S. government's Operation Warp Speed, a new national program aiming to provide substantial quantities of safe, effective vaccine for Americans by January 2021. Furthermore, INOVIO has expanded its Phase 1 trial to add older participants in additional cohorts and plans to initiate a Phase 2/3 efficacy trial this summer upon regulatory concurrence.
Acuity Brands (NYSE: AYI) 10.7% HIGHER; reported Q3 EPS of $1.94, $0.72 better than the analyst estimate of $1.22. Revenue for the quarter came in at $776 million versus the consensus estimate of $741.62 million.
J2 Global (NASDAQ: JCOM) 9.4% LOWER; Hindenburg Research negative
Synacor, Inc. (Nasdaq: SYNC) 8% LOWER; Synacor and Qumu Corporation (Nasdaq: QUMU) announced that the companies have mutually agreed to terminate their proposed all-stock merger agreement, previously announced on February 11, 2020.
Xilinx, Inc. (NASDAQ: XLNX) 7.5% HIGHER; sees Q1 revenue of $720-$730 million, versus the consensus of $690.3 million.
Micron Technology (NASDAQ: MU) 5.8% HIGHER; reported Q3 EPS of $0.82, $0.05 better than the analyst estimate of $0.77. Revenue for the quarter came in at $5.44 billion versus the consensus estimate of $5.31 billion. Micron Technology sees Q4 2020 EPS of $0.95-$1.15, versus the consensus of $0.81. Micron Technology sees Q4 2020 revenue of $5.75-6.25 billion, versus the consensus of $5.47 billion.
Simon Property Group (NYSE: SPG) 5% HIGHER; declared a quarterly dividend of $1.30 per share, or $5.20 annualized. This is a 38.1% decrease from the prior dividend of $2.10. Provides business update.
Avadel Pharmaceuticals (NASDAQ: AVDL) 4.5% HIGHER; H.C. Wainwright initiates coverage with a Buy rating and $15 price target.
CRISPR Therapeutics (NASDAQ: CRSP) 4.1% LOWER; announced that it is commencing an underwritten public offering of $325,000,000 of common shares. In addition, the underwriters will have a 30-day option to purchase up to an additional $48,750,000 of common shares at the public offering price less the underwriting discount.
Herman Miller (NASDAQ: MLHR) 3.5% LOWER; reported Q4 EPS of $0.11, $0.21 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $475.7 million versus the consensus estimate of $479.63 million.
lululemon athletica inc. (NASDAQ: LULU) 3.3% HIGHER; today announced that it has entered into a definitive agreement to acquire MIRROR, a leading in-home fitness company that created an interactive workout platform that features live and on-demand classes, for a purchase price of $500 million.
Acceleron Pharma Inc. (Nasdaq: XLRN) 2.9% LOWER; announced that it intends to offer and sell, subject to market and other conditions, $400 million of its common stock in an underwritten public offering.
Innovative Industrial Properties, Inc. (NYSE: IIPR) 2.8% LOWER; announced today that it has commenced a public offering of 1,800,000 shares of its common stock.
Peloton (NASDAQ: PTON) 2.1% LOWER; lower on news lululemon will acquire home fitness innovator MIRROR for $500 million.
Pluralsight (NASDAQ: PS) 1.4% HIGHER; KeyBanc initiates coverage on with an Overweight rating and a price target of $22.00.
Wells Fargo (WFC) 1.3% LOWER; expects its common stock dividend in third quarter 2020 will be reduced
Chegg (NYSE: CHGG) 1% HIGHER; KeyBanc initiates coverage on with an Overweight rating and a price target of $80.00.